Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1977 Aug;39(8):834–838. doi: 10.1136/hrt.39.8.834

Metoprolol--a new cardioselective beta-adrenoceptor blocking agent for treatment of tachyarrhythmias.

H S Wasir, R K Mahapatra, M L Bhatia, S B Roy, R Sannerstedt
PMCID: PMC483327  PMID: 901674

Abstract

The antiarrhythmic effect of the cardioselective beta-adrenoceptor blocking agent metoprolol, given intravenously, was studied in 44 patients with various tachyarrhythmias, including patients with congestive heart failure and signs of digitalis intoxication. All patients with atrial tachycardia (12 cases) reverted to normal sinus rhythm. In 3 out of 18 patients with atrial fibrillation, sinus rhythm was restored, and in the others there was a significant reduction in ventricular rate. In 6 of 10 patients with ventricular ectopic beats, and 1 of 2 patients with ventricular tachycardia, the ectopic rhythm was abolished. The drug was well tolerated, without any significant changes in blood pressure, even by patients with signs of digitalis intoxication and varying degrees of pulmonary or peripheral circulatory congestion. Metoprolol is of clinical value for treatment of tachyarrhythmias, especially those of supraventricular origin.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablad B., Borg K. O., Carlsson E., EK L., Johnson G., Malmfors T., Regårdh C. G. A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) 1975;36(Suppl 5):7–23. doi: 10.1111/j.1600-0773.1975.tb03318.x. [DOI] [PubMed] [Google Scholar]
  2. Ablad B., Carlsson E., Ek L. Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists. Life Sci I. 1973 Feb 1;12(3):107–119. doi: 10.1016/0024-3205(73)90368-8. [DOI] [PubMed] [Google Scholar]
  3. Bengtsson C. Comparison between metoprolol and propranolol as antihypertensive agents. A double-blind cross-over study. Acta Med Scand. 1976;199(1-2):71–74. doi: 10.1111/j.0954-6820.1976.tb06693.x. [DOI] [PubMed] [Google Scholar]
  4. Gent G., Davis T. C., McDonald A. Practolol in treatment of supraventricular cardiac dysrhythmias. Br Med J. 1970 Feb 28;1(5695):533–535. doi: 10.1136/bmj.1.5695.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gibson D. G., Balcon R., Sowton E. Clinical use of I.C.I. 50172 as an antidysrhythmic agent in heart failure. Br Med J. 1968 Jul 20;3(5611):161–163. doi: 10.1136/bmj.3.5611.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jewitt D. E., Mercer C. J., Shillingford J. P. Practolol in the treatment of cardiac dysrhythmias due to acute myocardial infarction. Lancet. 1969 Aug 2;2(7614):227–230. doi: 10.1016/s0140-6736(69)90001-4. [DOI] [PubMed] [Google Scholar]
  7. Lemberg L., Castellanos A., Jr, Arcebal A. G. The use of propranolol in arrhythmias complicating acute myocardial infarction. Am Heart J. 1970 Oct;80(4):479–487. doi: 10.1016/0002-8703(70)90195-x. [DOI] [PubMed] [Google Scholar]
  8. Sannerstedt R., Wasir H. Acute haemodynamic effects of metoprolol in hypertensive patients. Br J Clin Pharmacol. 1977 Feb;4(1):23–26. doi: 10.1111/j.1365-2125.1977.tb00661.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Singh B. N., Jewitt D. E. Beta-adrenergic receptor blocking drugs in cardiac arrhythmias. Drugs. 1974;7(6):426–461. doi: 10.2165/00003495-197407060-00004. [DOI] [PubMed] [Google Scholar]
  10. Stenberg J., Wasir H., Amery A., Sannerstedt R., Werkö L. Comparative hemodynamic studies in man of adrenergic bepta-1-receptors agents without (h 93/26 equal to metoprolol) or with (h 87/07) intrinsic sympathicomimetic activity. Acta Pharmacol Toxicol (Copenh) 1975;36(Suppl 5):76–84. doi: 10.1111/j.1600-0773.1975.tb03324.x. [DOI] [PubMed] [Google Scholar]
  11. Stephen S. A. Unwanted effects of propranolol. Am J Cardiol. 1966 Sep;18(3):463–472. doi: 10.1016/0002-9149(66)90071-3. [DOI] [PubMed] [Google Scholar]
  12. Wit A. L., Hoffman B. F., Rosen M. R. Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part A. Am Heart J. 1975 Oct;90(4):521–533. doi: 10.1016/0002-8703(75)90436-6. [DOI] [PubMed] [Google Scholar]
  13. Wit A. L., Hoffman B. F., Rosen M. R. Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part B. Am Heart J. 1975 Nov;90(5):665–675. doi: 10.1016/0002-8703(75)90231-8. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES